|
0.15% POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.30% SODIUM CHLORIDE INJECTION · 300 MG per 100 ML + 150 MG per 100 ML + 3.3 G per 100 ML · SOLUTION
|
B. BRAUN MEDICAL INC |
cancelled |
DIN
01931741DPD drug code
13034
|
|
0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.20% SODIUM CHLORIDE INJECTION USP · 150 MG per 100 ML + 200 MG per 100 ML + 5 G per 100 ML · SOLUTION
|
B. BRAUN MEDICAL INC |
authorised |
DIN
01931598DPD drug code
21753
|
|
0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.33% SODIUM CHLORIDE INJECTION USP · 330 MG per 100 ML + 5 G per 100 ML + 150 MG per 100 ML · LIQUID
|
B. BRAUN MEDICAL INC |
cancelled |
DIN
01931601DPD drug code
21754
|
|
0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION · 450 MG per 100 ML + 5 G per 100 ML + 150 MG per 100 ML · SOLUTION
|
B. BRAUN MEDICAL INC |
cancelled |
DIN
01931547DPD drug code
18991
|
|
0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION · 900 MG per 100 ML + 5 G per 100 ML + 150 MG per 100 ML · SOLUTION
|
B. BRAUN MEDICAL INC |
cancelled |
DIN
01931644DPD drug code
21755
|
|
0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP · 150 MG per 100 ML + 5 G per 100 ML · SOLUTION
|
B. BRAUN MEDICAL INC |
cancelled |
DIN
01931539DPD drug code
21713
|
|
0.30% POTASSIUM CHLORIDE IN 5% DEXTROSE · 300 MG per 100 ML + 5 G per 100 ML · LIQUID
|
B. BRAUN MEDICAL INC |
cancelled |
DIN
01967770DPD drug code
23494
|
|
0.30% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION · 300 MG per 100 ML + 450 MG per 100 ML + 5 G per 100 ML · SOLUTION
|
B. BRAUN MEDICAL INC |
cancelled |
DIN
01931571DPD drug code
21752
|
|
0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION · 0.4 % LIDOCAINE HYDROCHLORIDE IN 5 % INJECTABLE DEXTROSE · 50 MG per ML + 4 MG per ML · SOLUTION
|
BAXTER CORPORATION |
authorised |
DIN
00828602DPD drug code
10519
|
|
0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION USP · 4 MG per ML + 50 MG per ML · SOLUTION
|
HOSPIRA HEALTHCARE ULC |
cancelled |
DIN
00478288DPD drug code
5339
|
|
100GM GLUCOSE TOLERANCE DRINK · 10 G per 30 ML · LIQUID
|
CRITERION SCIENCES |
cancelled |
DIN
02003694DPD drug code
13548
|
|
10% DEXTRAN 40 IN 5% DEXTROSE INJECTION · 5 % per % + 10 % per % · SOLUTION
|
B. BRAUN MEDICAL INC |
cancelled |
DIN
01924249DPD drug code
21688
|
|
10% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP · 10 G per 100 ML + 900 MG per 100 ML · SOLUTION
|
B. BRAUN MEDICAL INC |
cancelled |
DIN
01927922DPD drug code
12787
|
|
10% DEXTROSE INJECTION USP · 100 MG per ML · SOLUTION
|
B. BRAUN MEDICAL INC |
authorised |
DIN
01924427DPD drug code
14251
|
|
10% DEXTROSE INJECTION, USP · 10 G per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02014823DPD drug code
18828
|
|
10% DEXTROSE INJECTION, USP · 10 G per 100 ML · SOLUTION
|
BAXTER CORPORATION |
authorised |
DIN
00060364DPD drug code
59976
|
|
13.3% DEXTROSE INJECTION, USP · 13.3 G per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02015072DPD drug code
18826
|
|
20% DEXTROSE INJECTION USP · 200 MG per ML · SOLUTION
|
B. BRAUN MEDICAL INC |
cancelled |
DIN
01924257DPD drug code
15538
|
|
20% DEXTROSE INJECTION, USP · 20 G per 100 ML · SOLUTION
|
BAXTER CORPORATION |
cancelled |
DIN
02015080DPD drug code
18827
|
|
(20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP · 3.3 G per 100 ML + 150 MG per 100 ML + 300 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION |
authorised |
DIN
00438014DPD drug code
3132
|
|
(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.2% SODIUM CHLORIDE INJECTION USP · 5 G per 100 ML + 150 MG per 100 ML + 200 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION |
cancelled |
DIN
00503142DPD drug code
10043
|
|
(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP · 5 G per 100 ML + 450 MG per 100 ML + 150 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION |
authorised |
DIN
00437999DPD drug code
10044
|
|
(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP · 150 MG per 100 ML + 900 MG per 100 ML + 5 G per 100 ML · SOLUTION
|
BAXTER CORPORATION |
authorised |
DIN
00786292DPD drug code
10866
|
|
(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP · 150 MG per 100 ML + 5 G per 100 ML · SOLUTION
|
BAXTER CORPORATION |
authorised |
DIN
00438049DPD drug code
10041
|
|
2.5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE · 145 MG per 100 ML + 182.5 MG per 100 ML + 520 MG per 100 ML + 29.3 MG per 100 ML + 45 MG per 100 ML + 170 MG per 100 ML + 10 G per 100 ML + 10 MG per 100 ML + 105 MG per 100 ML + 150 MG per 100 ML + 100 MG per 100 ML + 125 MG per 100 ML + 120 MG per 100 ML + 130.5 MG per 100 ML + 140 MG per 100 ML + 25.5 MG per 100 ML + 260 MG per 100 ML + 290 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02143267DPD drug code
20288
|
|
2.5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE CLINIMIX · 120 MG per 100 ML + 45 MG per 100 ML + 110 MG per 100 ML + 520 MG per 100 ML + 260 MG per 100 ML + 105 MG per 100 ML + 145 MG per 100 ML + 10 G per 100 ML + 10 MG per 100 ML + 115 MG per 100 ML + 155 MG per 100 ML + 130.5 MG per 100 ML + 29.3 MG per 100 ML + 25.5 MG per 100 ML + 170 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02013975DPD drug code
14069
|
|
2.5% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 10% DEXTROSE QUICKMIX · 195 MG per 100 ML + 155 MG per 100 ML + 520 MG per 100 ML + 260 MG per 100 ML + 120 MG per 100 ML + 105 MG per 100 ML + 10 MG per 100 ML + 110 MG per 100 ML + 10 G per 100 ML + 115 MG per 100 ML + 45 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02014106DPD drug code
19607
|
|
2.5%TRAVASOL AMINO ACID INJ.W.ELEC.W.25%DEX · 520 MG per 100 ML + 130.5 MG per 100 ML + 145 MG per 100 ML + 182.5 MG per 100 ML + 45 MG per 100 ML + 10 MG per 100 ML + 29.3 MG per 100 ML + 170 MG per 100 ML + 120 MG per 100 ML + 150 MG per 100 ML + 125 MG per 100 ML + 105 MG per 100 ML + 290 MG per 100 ML + 25 G per 100 ML + 260 MG per 100 ML + 140 MG per 100 ML + 100 MG per 100 ML + 25.5 MG per 100 ML · LIQUID
|
CLINTEC NUTRITION COMPANY |
cancelled |
DIN
02143259DPD drug code
20272
|
|
2.75% TRAVAS. AMINO ACID INJ.W.ELECW.25%DEX · 159.5 MG per 100 ML + 110 MG per 100 ML + 25 G per 100 ML + 570 MG per 100 ML + 154 MG per 100 ML + 201 MG per 100 ML + 165 MG per 100 ML + 283 MG per 100 ML + 115.5 MG per 100 ML + 112 MG per 100 ML + 51 MG per 100 ML + 187 MG per 100 ML + 261 MG per 100 ML + 215.5 MG per 100 ML + 49.5 MG per 100 ML + 11 MG per 100 ML + 316 MG per 100 ML + 137.5 MG per 100 ML + 132 MG per 100 ML · LIQUID
|
CLINTEC NUTRITION COMPANY |
cancelled |
DIN
02143232DPD drug code
20274
|
|
2.75% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 25% DEXTROSE QUICKMIX · 126 MG per 100 ML + 115 MG per 100 ML + 570 MG per 100 ML + 170 MG per 100 ML + 215.5 MG per 100 ML + 159 MG per 100 ML + 285 MG per 100 ML + 120.5 MG per 100 ML + 112 MG per 100 ML + 49.5 MG per 100 ML + 261 MG per 100 ML + 131.5 MG per 100 ML + 11 MG per 100 ML + 51 MG per 100 ML + 25 G per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02014009DPD drug code
19608
|
|
2.75% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 5% DEXTROSE QUICKMIX · 112 MG per 100 ML + 215.5 MG per 100 ML + 256 MG per 100 ML + 126 MG per 100 ML + 570 MG per 100 ML + 51 MG per 100 ML + 131.5 MG per 100 ML + 5 G per 100 ML + 159 MG per 100 ML + 170 MG per 100 ML + 285 MG per 100 ML + 49.5 MG per 100 ML + 11 MG per 100 ML + 115 MG per 100 ML + 120.5 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02013991DPD drug code
14070
|
|
2.75%TRAVASOL AMINO ACID INJ.W.ELEC.W.5%DEX. · 159.5 MG per 100 ML + 154 MG per 100 ML + 51 MG per 100 ML + 215 MG per 100 ML + 5 G per 100 ML + 261 MG per 100 ML + 570 MG per 100 ML + 137.5 MG per 100 ML + 165 MG per 100 ML + 187 MG per 100 ML + 283 MG per 100 ML + 115.5 MG per 100 ML + 201 MG per 100 ML + 132 MG per 100 ML + 112 MG per 100 ML + 110 MG per 100 ML + 316 MG per 100 ML + 11 MG per 100 ML + 49.5 MG per 100 ML · LIQUID
|
CLINTEC NUTRITION COMPANY |
cancelled |
DIN
02143240DPD drug code
20273
|
|
3.33% DEXTROSE AND 0.3% SODIUM CHLORIDE · 33.3 MG per ML + 3 MG per ML · SOLUTION
|
ICU MEDICAL CANADA INC |
cancelled |
DIN
00038881DPD drug code
2575
|
|
33.3% DEXTROSE INJECTION, USP · 33.3 G per 100 ML · SOLUTION
|
BAXTER CORPORATION |
cancelled |
DIN
02014831DPD drug code
18825
|
|
3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP · 300 MG per 100 ML + 3.3 G per 100 ML · SOLUTION
|
B. BRAUN MEDICAL INC |
authorised |
DIN
01927981DPD drug code
12711
|
|
40% DEXTROSE INJECTION, USP · 40 G per 100 ML · SOLUTION
|
BAXTER CORPORATION |
cancelled |
DIN
02014858DPD drug code
18823
|
|
40% DEXTROSE INJECTION USP · 40 % · SOLUTION
|
B. BRAUN MEDICAL INC |
cancelled |
DIN
01947230DPD drug code
22423
|
|
(40MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP · 300 MG per 100 ML + 3.3 G per 100 ML · SOLUTION
|
BAXTER CORPORATION |
authorised |
DIN
00438022DPD drug code
3133
|
|
(40MMOL/L)POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP · 450 MG per 100 ML + 300 MG per 100 ML + 5 G per 100 ML · SOLUTION
|
BAXTER CORPORATION |
authorised |
DIN
00438006DPD drug code
10045
|
|
(40 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP · 5 G per 100 ML + 300 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION |
authorised |
DIN
00438030DPD drug code
10042
|
|
4.25% AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 20% DEXTROSE QUICKMIX · 76 MG per 100 ML + 203 MG per 100 ML + 186 MG per 100 ML + 880 MG per 100 ML + 20 G per 100 ML + 263 MG per 100 ML + 17 MG per 100 ML + 246 MG per 100 ML + 178 MG per 100 ML + 195 MG per 100 ML + 440 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02013908DPD drug code
19606
|
|
4.25%TRAV. AMINO ACID INJ.W.O.ELECT.5%DEXT. · 246.5 MG per 100 ML + 5 G per 100 ML + 17 MG per 100 ML + 178.5 MG per 100 ML + 170 MG per 100 ML + 212.5 MG per 100 ML + 76.5 MG per 100 ML + 310 MG per 100 ML + 438 MG per 100 ML + 255 MG per 100 ML + 289 MG per 100 ML + 204 MG per 100 ML + 238 MG per 100 ML + 880 MG per 100 ML + 489 MG per 100 ML · LIQUID
|
CLINTEC NUTRITION COMPANY |
cancelled |
DIN
02142325DPD drug code
20284
|
|
4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE · 246.5 MG per 100 ML + 76.5 MG per 100 ML + 10 G per 100 ML + 77 MG per 100 ML + 51 MG per 100 ML + 17 MG per 100 ML + 212.5 MG per 100 ML + 297 MG per 100 ML + 489 MG per 100 ML + 289 MG per 100 ML + 261 MG per 100 ML + 178.5 MG per 100 ML + 204 MG per 100 ML + 170 MG per 100 ML + 310 MG per 100 ML + 880 MG per 100 ML + 238 MG per 100 ML + 255 MG per 100 ML + 438 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02142414DPD drug code
20276
|
|
4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 20% DEXTROSE · 20 G per 100 ML + 51 MG per 100 ML + 246.5 MG per 100 ML + 204 MG per 100 ML + 297 MG per 100 ML + 238 MG per 100 ML + 289 MG per 100 ML + 489 MG per 100 ML + 310 MG per 100 ML + 255 MG per 100 ML + 17 MG per 100 ML + 178.5 MG per 100 ML + 170 MG per 100 ML + 76.5 MG per 100 ML + 77 MG per 100 ML + 212.5 MG per 100 ML + 438 MG per 100 ML + 261 MG per 100 ML + 880 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02142406DPD drug code
20277
|
|
4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 20% DEXTROSE QUICKMIX · 297 MG per 100 ML + 261 MG per 100 ML + 263 MG per 100 ML + 186 MG per 100 ML + 17 MG per 100 ML + 178 MG per 100 ML + 880 MG per 100 ML + 77 MG per 100 ML + 203 MG per 100 ML + 76 MG per 100 ML + 20 G per 100 ML + 246 MG per 100 ML + 440 MG per 100 ML + 195 MG per 100 ML + 51 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02014033DPD drug code
19609
|
|
4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 25% DEXTROSE · 17 MG per 100 ML + 438 MG per 100 ML + 25 G per 100 ML + 246.5 MG per 100 ML + 297 MG per 100 ML + 880 MG per 100 ML + 76.5 MG per 100 ML + 170 MG per 100 ML + 310 MG per 100 ML + 261 MG per 100 ML + 212.5 MG per 100 ML + 238 MG per 100 ML + 178.5 MG per 100 ML + 489 MG per 100 ML + 51 MG per 100 ML + 289 MG per 100 ML + 255 MG per 100 ML + 204 MG per 100 ML + 77 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02142392DPD drug code
20292
|
|
4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 5% DEXTROSE QUICKMIX · 178 MG per 100 ML + 263 MG per 100 ML + 76 MG per 100 ML + 195 MG per 100 ML + 203 MG per 100 ML + 261 MG per 100 ML + 51 MG per 100 ML + 186 MG per 100 ML + 297 MG per 100 ML + 5 G per 100 ML + 880 MG per 100 ML + 246 MG per 100 ML + 77 MG per 100 ML + 440 MG per 100 ML + 17 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02014017DPD drug code
19604
|
|
4.25% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTRLYTES IN 10% DEXTROSE · 76.5 MG per 100 ML + 170 MG per 100 ML + 246.5 MG per 100 ML + 255 MG per 100 ML + 880 MG per 100 ML + 489 MG per 100 ML + 17 MG per 100 ML + 289 MG per 100 ML + 178.5 MG per 100 ML + 10 G per 100 ML + 212.5 MG per 100 ML + 438 MG per 100 ML + 238 MG per 100 ML + 204 MG per 100 ML + 310 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02142317DPD drug code
20289
|
|
4.25% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 20% DEXTROSE · 178.5 MG per 100 ML + 212.5 MG per 100 ML + 17 MG per 100 ML + 246.5 MG per 100 ML + 489 MG per 100 ML + 20 G per 100 ML + 238 MG per 100 ML + 289 MG per 100 ML + 204 MG per 100 ML + 438 MG per 100 ML + 310 MG per 100 ML + 880 MG per 100 ML + 76.5 MG per 100 ML + 255 MG per 100 ML + 170 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02142309DPD drug code
20304
|
|
4.25% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 25% DEXTROSE · 246.5 MG per 100 ML + 204 MG per 100 ML + 310 MG per 100 ML + 255 MG per 100 ML + 489 MG per 100 ML + 25 G per 100 ML + 238 MG per 100 ML + 170 MG per 100 ML + 178.5 MG per 100 ML + 880 MG per 100 ML + 76.5 MG per 100 ML + 438 MG per 100 ML + 17 MG per 100 ML + 212.5 MG per 100 ML + 289 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02142295DPD drug code
20303
|